Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-008362
Filing Date
2024-12-12
Accepted
2024-12-12 16:01:35
Documents
2
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3446
2 POA aobenshainpoa1.txt EX-24 3240
  Complete submission text file 0001562180-24-008362.txt   8258
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Issuer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BLUEBIRD BIO, INC. 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address
Obenshain Andrew (Reporting) CIK: 0001839697 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35966 | Film No.: 241544774